- Inspection year
- 2021
- Report date
- 31-Aug-2022
- PCAOB release
- 104-2022-181
- Audits reviewed
- 1
- Audits w/ Part I.A deficiencies
- 1
- Part I.A deficiency rate
- 100%
- Part I.A deficiencies
- 6
- Part I.B deficiencies
- 3
- Report
- View PDF ↗
Deficiencies (6)
Grouped by issuer and in the same order as the PCAOB report, so each item ties back directly to the source.
Issuer A6 deficiencies
| # | Area | Deficiency | Standard | Flags |
|---|---|---|---|---|
| 1 | Significant Accounts | The firm did not evaluate beyond reviewing issuer documentation the issuer's adoption of new accounting principles. (AS 2810.30) Financial statement audit only | AS 2810.30 | |
| 2 | Significant Accounts | The firm did not identify and evaluate the significance to the financial statements of the issuer's omission of certain required disclosures under GAAP. (AS 2810.30 and .31) Financial statement audit only | AS 2810.30; AS 2810.31 | |
| 3 | Significant Accounts | The firm did not perform procedures to test whether the significant account was appropriately recorded. (AS 2301.08) Financial statement audit only | AS 2301.8 | |
| 4 | Significant Accounts | The firm used an issuer-prepared schedule and certain system-generated reports in certain of its substantive procedures to test this significant account but did not test the accuracy and completeness of the schedule and reports. (AS 1105.10) Financial statement audit only | AS 1105.10 | |
| 5 | Significant Accounts | The firm used issuer-prepared schedules in certain other of its substantive procedures to test this significant account but did not test the completeness of the schedules. (AS 1105.10) Financial statement audit only | AS 1105.10 | |
| 6 | Financial Statement Presentation and Disclosures | The firm did not evaluate whether the financial statement presentation and disclosures associated with certain transactions were in conformity with GAAP. (AS 2810.30 and .31) Financial statement audit only | AS 2810.30; AS 2810.31 |